Sabtu, 12 Desember 2020

Google Alert - Business

Google
Business
Daily update December 13, 2020
NEWS
The New York Times
The Food and Drug Administration authorized Pfizer's Covid-19 vaccine for emergency use on Friday, clearing the way for millions of highly vulnerable people to begin receiving the vaccine within days. The authorization is a historic turning point in a ...
Facebook Twitter Flag as irrelevant
The New York Times
The F.D.A. authorized Pfizer's vaccine for emergency use on Friday, clearing the way for millions of people to begin receiving it within days. Up to 300,000 cases have been traced to a Boston Biotech conference held by Biogen in February. RIGHT NOW.
Facebook Twitter Flag as irrelevant
Washington Post
Hospitals that have spent months preparing to receive and administer a vaccine against a virus that has killed more than 295,000 people in the United States will begin receiving shipments of the shots on Monday, U.S. officials said Saturday morning, ...
Facebook Twitter Flag as irrelevant
Bloomberg
For all the headline-making drama surrounding Elon Musk and his brainchild Tesla Inc., investors were rewarded handsomely for their patience this year. Now that the company is maturing into blue-chip status with its addition to the S&P 500 Index this month, ...
Facebook Twitter Flag as irrelevant
Bloomberg
The unrelenting pace of inflows heading for China's bonds and stocks has one yuan bull predicting the currency could strengthen to a level not seen in nearly three decades. A "flood" of foreign cash will chase yuan-denominated assets in 2021 because they'll ...
Facebook Twitter Flag as irrelevant
USA TODAY
The vaccine will be sent to to 636 hospitals, clinics and public health systems nationwide, with 145 sites receiving doses Monday, 425 on Tuesday and the final 66 on Wednesday, Perna said. No vaccine doses were positioned in advance, he said.
Facebook Twitter Flag as irrelevant
Bloomberg
An interesting thing keeps happening in the American stock market. Lately, when ownership of young companies passes from the institutions who nurtured them into the much broader arms of the investing public, their valuations double. It happens fast.
Facebook Twitter Flag as irrelevant
Reuters
FRANKFURT (Reuters) -Britain's AstraZeneca has agreed to buy U.S. drugmaker Alexion Pharmaceuticals for $39 billion in its largest ever deal, diversifying away from its fast-growing cancer business in a bet on rare-disease and immunology drugs. Vials of ...
Facebook Twitter Flag as irrelevant
CNBC
"If you want to speculate, this is the time to do it, just speculate wisely," CNBC's Jim Cramer said. "You've got my blessing to buy stocks into weakness as we move closer to the long-awaited vaccine, even if the much-needed stimulus bill is still up in the air," ...
Facebook Twitter Flag as irrelevant
BBC News
At the start of the pandemic, we were warned: it takes years to develop a vaccine, so don't expect too much too soon. Now, after only 10 months, the injections have begun and the firms behind the front-runners are household names. As a result, investment ...
Facebook Twitter Flag as irrelevant
See more results | Edit this alert
You have received this email because you have subscribed to Google Alerts.
RSS Receive this alert as RSS feed
Send Feedback

Tidak ada komentar:

Posting Komentar